NAVIDEA BIOPHARMACEUTICALS I's ticker is and the CUSIP is 63937X953. A total of 2 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $10,000 | +100.0% | 19,100 | +365.9% | 0.00% | – |
| Q4 2015 | $5,000 | -50.0% | 4,100 | -6.8% | 0.00% | – |
| Q3 2015 | $10,000 | +11.1% | 4,400 | -4.3% | 0.00% | – |
| Q4 2014 | $9,000 | +12.5% | 4,600 | -24.6% | 0.00% | – |
| Q3 2014 | $8,000 | +166.7% | 6,100 | +205.0% | 0.00% | – |
| Q2 2014 | $3,000 | -40.0% | 2,000 | -28.6% | 0.00% | – |
| Q1 2014 | $5,000 | -83.3% | 2,800 | -81.0% | 0.00% | – |
| Q4 2013 | $30,000 | -6.2% | 14,700 | +23.5% | 0.00% | – |
| Q3 2013 | $32,000 | -64.4% | 11,900 | -64.8% | 0.00% | – |
| Q2 2013 | $90,000 | – | 33,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 149,800 | $310,000 | 0.01% |
| Citadel Advisors | 14,700 | $30,000 | 0.00% |